Cerity Partners LLC Makes New Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cerity Partners LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 17,800 shares of the medical instruments supplier’s stock, valued at approximately $482,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. UMB Bank n.a. boosted its position in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $27,000. LRI Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the last quarter. Rothschild Investment LLC bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at approximately $32,000. Finally, Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA in the third quarter worth approximately $35,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on XRAY shares. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. UBS Group reduced their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Eight equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $28.40.

DENTSPLY SIRONA Trading Down 1.2 %

DENTSPLY SIRONA stock opened at $19.08 on Friday. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market capitalization of $3.79 billion, a PE ratio of -9.22, a PEG ratio of 1.91 and a beta of 0.96. The business’s 50-day simple moving average is $21.86 and its 200-day simple moving average is $24.46.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same period in the previous year, the business posted $0.49 EPS. The company’s revenue for the quarter was up .4% on a year-over-year basis. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.